Eve Biomedical Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Eve Biomedical General Information

Description

Provider of biotechnology services intended to offer genomic and personalized medicines. The company's services offer a compact DNA sequencing system that will be able to sequence the whole human genome at lower costs thus helping to break the barrier of introducing sequencing in clinical diagnostics and jump-start the era of genomic medicine, enabling healthcare professionals to develop advanced methods of diagnosis.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 67 East Evelyn Avenue
  • Suite 5
  • Mountain View, CA 94041
  • United States
+1 (408)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 67 East Evelyn Avenue
  • Suite 5
  • Mountain View, CA 94041
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eve Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Feb-2019 Completed Out of Business
3. Grant 01-Jan-2014 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Dec-2012 $5.85M $7.63M Completed Generating Revenue
1. Early Stage VC (Series A) 04-May-2012 $1.78M $1.78M Completed Generating Revenue
To view Eve Biomedical’s complete valuation and funding history, request access »

Eve Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Eve Biomedical’s complete cap table history, request access »

Eve Biomedical Patents

Eve Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014218911-A1 Methods and compositions for nanostructure-based nucleic acid sequencing Active 20-Feb-2013
AU-2014218911-B2 Methods and compositions for nanostructure-based nucleic acid sequencing Inactive 20-Feb-2013
CA-2900921-A1 Methods and compositions for nanostructure-based nucleic acid sequencing Inactive 20-Feb-2013
EP-2958927-A2 Methods and compositions for nanostructure-based nucleic acid sequencing Inactive 20-Feb-2013
EP-2958927-A4 Methods and compositions for nanostructure-based nucleic acid sequencing Inactive 20-Feb-2013 C12Q1/6869
To view Eve Biomedical’s complete patent history, request access »

Eve Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eve Biomedical FAQs

  • When was Eve Biomedical founded?

    Eve Biomedical was founded in 2006.

  • Where is Eve Biomedical headquartered?

    Eve Biomedical is headquartered in Mountain View, CA.

  • What is the size of Eve Biomedical?

    Eve Biomedical has 11 total employees.

  • What industry is Eve Biomedical in?

    Eve Biomedical’s primary industry is Biotechnology.

  • Is Eve Biomedical a private or public company?

    Eve Biomedical is a Private company.

  • What is Eve Biomedical’s current revenue?

    The current revenue for Eve Biomedical is .

  • How much funding has Eve Biomedical raised over time?

    Eve Biomedical has raised $7.63M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process